CNVVY News and Press, ConvaTec Group Plc ADR From 10/27/23

2023-10-27 11:29:18 ET Summary Q3 results were impacted by customer returns related to the Boston facility recall, but the Codman Specialty Surgical business performed well. The reopening of the Boston facility is on track, but facility remediation can be a complicated process, an...

2023-10-12 16:31:15 ET Summary Smith & Nephew's shares have fallen over 20% this summer, despite ongoing improvements in the company's operations, as ortho stocks have been especially weak. The impact of GLP-1 drugs on the knee replacement market is uncertain; reduced obesity ...

2023-10-12 05:03:31 ET Summary Coloplast's shares have lagged behind other medical device companies on worries over margin pressure and aggressive moves to accelerate long-term growth. The company is expected to report organic revenue growth of around 8% for FQ4'23, but concerns r...

2023-08-16 11:28:28 ET ConvaTec Group ( OTCPK:CNVVY ) had declared $0.0561/share semi-annual dividend. Payable Oct. 13; for shareholders of record Aug. 18; ex-div Aug. 17. See CNVVY Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: ...

FDA clears first placental extracellular matrix medical device for management of second-degree burns PR Newswire Convatec technology is only medical device of its kind MEMPHIS, Tenn. , March 2, 2023 /PRNewswire/ -- Convatec has received clearance from...

Summary Bausch + Lomb has had a rocky time over the past few quarters, with sales coming under pressure and margins contracting. Most of the issues, though, seem transitory in nature and the firm is likely to see some improvement moving forward even though some issues might be longer la...

ConvaTec Group Plc (CNVVF) Q2 2022 Results Conference Call August 4, 2022 04:00 AM ET Company Participants Karim Bitar - Chief Executive Officer Jonny Mason - Chief Financial Officer Conference Call Participants Hassan Al-Wakeel - Barclays Paul Cuddon...

ConvaTec Group Plc (CNVVF) Q4 2021 Earnings Conference Call March 8, 2022 04:00 ET Company Participants Kate Postans - Investor Relations Karim Bitar - Chief Executive Officer Frank Schulkes - Chief Financial Officer Conference Call Participants Charles Weston - RBC Christian Glennie - Stifel...

ConvaTec, a global medical products company providing therapies focused on managing chronic conditions, has picked Veeva (NYSE:VEEV) Vault CDMS to provide electronic data capture, coding, and data cleaning for their upcoming study on the detection of wound infections. A secondary objecti...

ConvaTec ([[CNVVY]]) has been awarded a contract for Ostomy products with Vizient; agreement effective July 1 and will extend until June.30, 2024."The extension of the Vizient agreement will provide continuity for our current customers as well as allow us to focus on growth of our market...